彩色多普勒超声在乳腺癌患者新辅助化疗疗效评估中的应用价值

doi:10.3969/j.issn.1671-7171.2018.03.027

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To evaluate the value of color Doppler ultrasound (CDU) in evaluating the curative effect of neoadjuvant chemotherapy in patients with breast cancer.【Methods】A total of 200 patients were examined with CDU before and after neoadjuvant chemotherapy. The tumor volume, two-dimensional ultrasonic findings, blood flow grade of lesions and resistance index (RI) were compared between patients with different curative effect.【Results】CDU showed CR+PR in 130 cases and SD+PD in 70 cases. With the pathological results as the gold standard, the sensitivity and accuracy of CDU in evaluating the curative effect of neoadjuvant chemotherapy were 85.29% and 71.00%, respectively. The tumor volume of CR+PR group was significantly smaller than that of the same group before chemotherapy and SD+PD group after chemotherapy (P<0.05). After chemotherapy, rates of clear boundary, regular shape, clear internal echo and normal rear echo in the PR group were significantly higher while rate of rich blood flow and RI value were significantly lower than those before chemotherapy (P<0.05). There was no significant differences of above indexes in the SD+PD group before and after chemotherapy (P>0.05).【Conclusion】CDU can be used to objectively and effectively evaluate the curative effect of chemotherapy in treatment of breast cancer through two-dimensional ultrasonic findings and blood flow signals.

Key words： Breast Neoplasms/DT Breast Neoplasms/US Chemotherapy, Adjuvant

Received: 15 March 2017

PACS:

R737.9

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	RUAN Si-ni
	HU Ya-fei

Cite this article:

RUAN Si-ni,HU Ya-fei. Value of Color Doppler Ultrasound in Evaluating the Curative Effect of Neoadjuvant Chemotherapy in Patients with Breast Cancer[J]. JOURNAL OF CLINICAL RESEARCH, 2018, 35(3): 504-507.

URL:

http://www.jcr.net.cn/EN/10.3969/j.issn.1671-7171.2018.03.027 OR http://www.jcr.net.cn/EN/Y2018/V35/I3/504

[1] 陈潇,叶大才,关海天,等.彩色多普勒超声评估乳腺癌新辅助化疗疗效的应用价值[J].实用癌症杂志,2016,31(9):1459-1461,1465.
[2] Adler DD,Carson PL,Rubin JM,et al.Doppler ultrasound color flow i-maging in the study of breast cancer:preliminary findings[J].Ultrasound Med Biol,1990,16(6):553-559.
[3] RECIST.Response evaluation criteria in solid tumors [J].J Natl Cancer Inst,2000,92(3):179-181.
[4] Smith IC.Neoadjuvant chemotherapy in bre-ast cancer:significantly enhanced response with docetaxel[J].J Clin Oncol,2002,20(6):1456-1466.
[5] 陆清,江科,李琼,等.高频超声联合钼靶检测在早期乳腺癌诊断中的应用价值[J].医学临床研究,2015,32(2):229-231.
[6] 龚念梅,吴静,吴彬彬,等.彩色多普勒超声联合CT用于临床乳腺癌诊断价值分析与随机对照评价[J].中国CT和MRI杂志,2015,13(8):51-53.
[7] 张林,郝洁,王立平,等.乳腺超声造影、彩色多普勒超声及磁共振灌注成像在评估乳腺癌新辅助化疗疗效中的对比研究[J].华中科技大学学报(医学版),2014,43(4):449-452.
[8] Oertel J,Gaab MR,Tschan CA,et al.Mononostril endoscopic transsphenoidal approach to sellar and peri-sellar lesions:Personal experience and literature review[J].Br J Neurosurg,2015,29(4):532-537.[9] 李朝喜,刘杨,刘俊峰,等.彩色多普勒超声对乳腺癌新辅助化疗疗效的评价研究[J].现代生物医学进展,2015,15(17):3325-3328.
[10] 王莉,陈文有,张蓉,等.彩色多普勒超声对乳腺癌的诊断价值及对乳腺癌新辅助化疗疗效评价[J].山西医药杂志,2014,43(16):1910-1912.
[11] 刘晓婷.彩色多普勒超声在乳腺癌新辅助化疗疗效评价上的应用价值[J].中国临床医学影像杂志,2011,22(12):876-878.
[12] 刘佳,俞磊,施勇,等.彩色多普勒超声应用于乳腺癌新辅助化疗疗效评估的价值分析[J].临床和实验医学杂志,2017,16(2):154-156.